These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 26670555)

  • 1. In brief: oral phenylephrine for nasal congestion.
    Med Lett Drugs Ther; 2015 Dec; 57(1484):174. PubMed ID: 26670555
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral Phenylephrine HCl for Nasal Congestion in Seasonal Allergic Rhinitis: A Randomized, Open-label, Placebo-controlled Study.
    Meltzer EO; Ratner PH; McGraw T
    J Allergy Clin Immunol Pract; 2015; 3(5):702-8. PubMed ID: 26143019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Over-the-Counter Oral Phenylephrine: A Placebo for Nasal Congestion.
    Hatton RC; Hendeles L
    J Allergy Clin Immunol Pract; 2015; 3(5):709-10. PubMed ID: 26362551
    [No Abstract]   [Full Text] [Related]  

  • 4. Phenylephrine hydrochloride modified-release tablets for nasal congestion: a randomized, placebo-controlled trial in allergic rhinitis patients.
    Meltzer EO; Ratner PH; McGraw T
    Ann Allergy Asthma Immunol; 2016 Jan; 116(1):66-71. PubMed ID: 26560899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of an extended-release formulation of desloratadine and pseudoephedrine vs the individual components in the treatment of seasonal allergic rhinitis.
    Pleskow W; Grubbe R; Weiss S; Lutsky B
    Ann Allergy Asthma Immunol; 2005 Mar; 94(3):348-54. PubMed ID: 15801245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal management of nasal congestion caused by allergic rhinitis in children: safety and efficacy of medical treatments.
    Scadding G
    Paediatr Drugs; 2008; 10(3):151-62. PubMed ID: 18454568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of topical nasal decongestants.
    Connell JT
    Ann Allergy; 1969 Nov; 27(11):541-6. PubMed ID: 4195892
    [No Abstract]   [Full Text] [Related]  

  • 8. Improving the management and quality of life of patients with allergic rhinitis.
    Carr V
    Prof Nurse; 2005 Apr; 20(8):31-3. PubMed ID: 15819315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical assessment of nasal decongestion test by VAS in adolescents.
    Marseglia GL; Cirillo I; Klersy C; Caimmi D; Caimmi S; Castellazzi AM; Ciprandi G
    Pediatr Allergy Immunol; 2009 Mar; 20(2):187-91. PubMed ID: 18422891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parental perception of the effectiveness of treatments for infant nasal congestion.
    Krugman SD; Bhagtani HR
    Clin Pediatr (Phila); 2013 Aug; 52(8):762-4. PubMed ID: 22399567
    [No Abstract]   [Full Text] [Related]  

  • 11. Double-blind comparison of metizoline hydrochloride (Ellsyl) and phenylephrine in allergic and vasomotor rhinitis.
    Zumpft CW
    Curr Ther Res Clin Exp; 1975 Jan; 17(1):40-6. PubMed ID: 49255
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute coronary syndrome after nasal spray of oxymetazoline.
    Montastruc F; Montastruc G; Taudou MJ; Olivier-Abbal P; Montastruc JL; Bondon-Guitton E
    Chest; 2014 Dec; 146(6):e214-e215. PubMed ID: 25451367
    [No Abstract]   [Full Text] [Related]  

  • 13. Relief of cough and nasal symptoms associated with allergic rhinitis by mometasone furoate nasal spray.
    Gawchik S; Goldstein S; Prenner B; John A
    Ann Allergy Asthma Immunol; 2003 Apr; 90(4):416-21. PubMed ID: 12722964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desloratadine and pseudoephedrine combination therapy as a comprehensive treatment for allergic rhinitis and nasal congestion.
    Anolik R
    Expert Opin Drug Metab Toxicol; 2009 Jun; 5(6):683-94. PubMed ID: 19473112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nasal congestion index: A measure for nasal obstruction.
    Kjaergaard T; Cvancarova M; Steinsvåg SK
    Laryngoscope; 2009 Aug; 119(8):1628-32. PubMed ID: 19507219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and management of nasal congestion: the role of intranasal corticosteroids.
    Benninger M
    Postgrad Med; 2009 Jan; 121(1):122-31. PubMed ID: 19179820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible nasal airway obstruction: does change in nasal peak inspiratory flow following decongestion predict response to topical steroids in chronic rhinosinusitis patients?
    Koo Ng NK; Young D; McGarry GW
    J Laryngol Otol; 2012 Dec; 126(12):1238-40. PubMed ID: 23057871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The influence of desloratadine on course of intermittens allergic rhinitis].
    Buczyłko K; Chwała C; Zielińska-Bliźniewska H; Wagner A; Dzwonnik A
    Pol Merkur Lekarski; 2005 Feb; 18(104):133-40. PubMed ID: 17877116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of nasal decongestion on nasalance measures.
    Pegoraro-Krook MI; Dutka-Souza JC; Williams WN; Teles Magalhães LC; Rossetto PC; Riski JE
    Cleft Palate Craniofac J; 2006 May; 43(3):289-94. PubMed ID: 16681401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Administration times for intranasal drops].
    Ahrens P
    Med Monatsschr Pharm; 2004 Jan; 27(1):23-4. PubMed ID: 14752930
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.